Supplementary Materials

This PDF file includes:

  • Fig. S1. Circular maps of AAV8 plasmid expression vectors carrying PON1-IF11 under tissue-specific promoters.
  • Fig. S2. SDS-PAGE analysis of the purified AAV8-PON1-IF11 viral particles.
  • Table S1. Concentration of PON1-IF11 in mouse blood on days 17 and 42 after AAV8-TBG-PON1-F11 injection.
  • Table S2. PON1-IF11 concentration in mouse plasma required to afford protection against GD and GF.
  • Table S3. PON1-IF11 concentration in mouse plasma required to afford protection against GB and GA.

[Download PDF]